Avid Bioservices Inc (CDMO)

[biopharm]

I understand but what of Omeros? No one is mentioning they just published Sept 10, 2019 that there are two brakes and PS Targeting required

PS Regulates Tumor Immunity

If one reads that post again, I don't see Omeros publishing how important PS Targeting is on Sept 10, 2019

More importantly, they (Omeros) have MORE unpublished data that is being held back as they say it will be presented at a future conference